Comparative Study of Topical Sucralfate and Normal Saline Dressing for Diabetic Ulcer-A Quasi-Experimental Study
DOI:
https://doi.org/10.51253/pafmj.v76i1.12445Keywords:
Diabetic foot, Dressings, Sucralfate, Saline solution, Wound healing.Abstract
Objective: To compare the effect of topical Sucralfate versus normal saline dressing in wound healing of diabetic ulcers.
Study Design: Quasi-experimental.
Place and Duration of Study: Department of Surgery, Combined Military Hospital, Multan Pakistan from Jan to Jun 2023.
Methodology: The study included 64 diabetic patients aged 25-75 years with long-standing diabetic grade 1 and 2 ulcers. Participants were distributed in 2 equal Groups by lottery method. Group-A patients were planned for topical Sucralfate dressings, whereas Group-B patients received normal saline dressings. The mean reduction in wound area and healing time were assessed and compared in both Groups.
Results: Out of 64 patients, 56 patients were included in the final analysis and eight were excluded due to death or complications. The mean age was 56.21±9.58 years in the topical Sucralfate Group and 57.70±12.01 years in the normal saline Group. The mean wound surface area was 185.24±22.01 cm2 in Group-A and 186.67±19.17 cm2 in Group-B (p=0.907). In weeks 1 and 3, the Sucralfate dressing Group showed more reduction in surface area, 12.31±2.23% and 72.69±9.54 %, respectively, whereas the normal saline Group had 10.59±2.56% and 47.44±6.99% reduction in wound size respectively (p<0.005). Healing time in the topical Sucralfate Group was less than in the normal saline Group, 26.38±2.63 days vs 36.96±3.79 days, respectively (p<0.005).
Conclusion: Topical Sucralfate dressings have been shown to be more successful and effective in treating diabetic ulcers than conventional normal saline dressings.
Downloads
References
Azeem S, Khan U, Liaquat A. The increasing rate of diabetes in Pakistan: A silent killer. Ann Med Surg 2022; 79(1): 103901. https://doi.org/10.1016/j.amsu.2022.103901
2. Khan A, Junaid N. Prevalence of diabetic foot syndrome amongst population with type 2 diabetes in Pakistan in primary care settings. J Pak Med Assoc 2017; 67(12): 1818-1824.
3. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med 2017; 376(24): 2367-2375.
https://doi.org/10.1056/NEJMra1615439
4. Udovichenko OV, Maximova NV, Amosova MV, Yunilaynen OA, Berseneva EA, Starostina EG. Prevalence and Prognostic Value of Depression and Anxiety in Patients with Diabetic Foot Ulcers and Possibilities of their Treatment. Curr Diabetes Rev 2017; 13(1): 97-106.
https://doi.org/10.2174/1573399812666160523143354
5. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis †. Ann Med 2017; 49(2): 106-116.
https://doi.org/10.1080/07853890.2016.1231932
6. Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG, Pacella RE et al. Global Disability Burdens of Diabetes-Related Lower-Extremity Complications in 1990 and 2016. Diabetes Care 2020; 43(5): 964-974.
https://doi.org/10.2337/dc19-1614
7. Boyko EJ, Zelnick LR, Braffett BH, Pop-Busui R, Cowie CC, Lorenzi GM, et al. Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 2022; 45(2): 357-364.
https://doi.org/10.2337/dc21-1816
8. Dayya D, O'Neill OJ, Huedo-Medina TB, Habib N, Moore J, Iyer K et al. Debridement of Diabetic Foot Ulcers. Adv Wound Care 2022; 11(12): 666-686.
https://doi.org/10.1089/wound.2021.0016
9. Zheng HB, Len M, Pattamanuch N. Effective Use of Topical Sucralfate in the Conservative Management of Expanded Gastrostomy Tract Reduction. J Pediatric Gastroenterol Nutrition Rep 2021; 2(3): e111.
https://doi.org/10.1097/PG9.0000000000000111
10. Rudiman R, Hanafi RV, Evan C, Halim F. The efficacy of topical sucralfate in improving pain and wound healing after haemorrhoidectomy procedure: A systematic review, meta-analysis, and meta-regression of randomised clinical trials. Int Wound J 2023; 20(2): 543-553.
https://doi.org/10.1111/iwj.13901
11. Bhatmule A, Janugade HB, Nangare N. A competitive study of topical sucralfate and ordinary saline for diabetic ulcer dressing. J Pharmaceut Negative Results 2022: 577-580.
https://doi.org/10.47750/pnr.2022.13.S06.081
12. Nagalakshmi G, Amalan AJ, Anandan H. Clinical Study of Comparision Between Efficacy of Topical Sucralfate and Conventional Dressing in the Managment of Diabetic Ulcer. Int J Sci Stud 2017; 5(3): 236-238.
https:// doi: 10.17354/ijss/2017/302
13. Monteiro-Soares M, Russell D, Boyko EJ, Jeffcoate W, Mills JL, Morbach S, et al. International Working Group on the Diabetic Foot (IWGDF). Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev 2020; 36 Suppl 1: e3273. https://doi.org/10.1002/dmrr.3273
14. Ibrahim A. IDF Clinical Practice Recommendation on the Diabetic Foot: A guide for healthcare professionals. Diabetes Res Clin Pract 2017 May; 127: 285-287.
https://doi.org/10.1016/j.diabres.2017.04.013
15. Rani BS, Prakash GV, Sarada B. A comparative study of topical sucralfate and povidone iodine dressing in diabetic foot ulcers in a tertiary care hospital in Tirupati. J Evid Based Med Health 2021; 8(34): 3200-3204.
https://doi.org/10.18410/jebmh/2021/582
16. Kumar A, Sharma AK, Singh AK. A comparative study of topical sucralfate Versus normal saline for dressing of diabetic ulcer. International J Health Clinical Res 2021; 4(19): 101–103.
17. Gnanakkumar T. Efficacy of Topical Sucralfate and Conventional Dressing in the Treatment of Diabetic Ulcer. Int J Sci Stud 2021; 9(7): 63-66.
18. Chatterjee N, Ekka NM, Mahajan M, Kumar B, Kumar N, Zia A. Effectiveness of Topical Sucralfate in the Management of Diabetic Foot Ulcers: An Open-Labeled Randomized Study. Cureus 2023;. https://doi.org/10.7759/cureus.37570
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sajjad Ahmad Ansari, Nadia Riaz , Dr Abdul Majid, Zain Farooq, Muhammad Waqas Ahmed Bhati, Afzal Saeed Awan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





